TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs
- 28 August 2008
- journal article
- research article
- Published by Elsevier in Biomaterials
- Vol. 29 (33), 4429-4438
- https://doi.org/10.1016/j.biomaterials.2008.08.004
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Interactions of cell penetrating peptide Tat with model membranes: A biophysical studyBiochemical and Biophysical Research Communications, 2007
- Induction of P-glycoprotein expression and activity by ritonavir in bovine brain microvessel endothelial cellsJournal of Pharmacy and Pharmacology, 2007
- Inhibition of P-glycoprotein Activity at the Primate Blood-Brain Barrier Increases the Distribution of Nelfinavir into the Brain but Not into the Cerebrospinal FluidPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2007
- Complexes of DNA with cationic peptides: Conditions of formation and factors effecting internalization by mammalian cellsBiochemistry (Moscow), 2006
- Trans-Activating Transcriptional Activator (TAT) Peptide-Mediated Brain Drug DeliveryJournal of Biomedical Nanotechnology, 2006
- Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiencyBiochemical and Biophysical Research Communications, 2005
- Evaluation of the MDR-MDCK cell line as a permeability screen for the blood–brain barrierInternational Journal of Pharmaceutics, 2004
- Brain Delivery of HIV Protease InhibitorsArchiv der Pharmazie, 2003
- In Vivo Protein Transduction: Delivery of a Biologically Active Protein into the MouseScience, 1999
- Synthesis and pharmacokinetics of a dihydropyridine chemical delivery system for the antiimmunodeficiency virus agent, dideoxycytidineJournal of Medicinal Chemistry, 1993